Q2i is a digital health company that focuses on innovation, development, and supplying evidence-based technology to improve treatment for Substance Use Disorder (SUD). Their solutions consist of patient mobile applications that connect to a healthcare team portal, enhancing connection, communication, support, and insight for patients. Q2i's technology-enabled contingency management solutions are a significant scientific and clinical advancement in the treatment of SUD.

Their products include the Opioid Addiction Recovery Support App, which helps primary care providers improve the success of their MOUD treatment programs by increasing treatment plan adherence and reducing program dropouts and missed appointments. The Opioid Addiction Recovery Support-CM App improves the successful transition of patients from emergency and acute care departments to outpatient care, reducing hospital readmissions. Q2i also offers the Continuing Alumni Support Application, designed for residential or intensive outpatient treatment programs to improve post-treatment care and long-term success for patients in recovery.

Lastly, their Probation and Reentry Coach Application aims to reduce revocation and recidivism rates while improving the success rate of probation and reentry programs implemented by justice teams. With Q2i's technology, patient engagement and adherence to treatment plans are increased significantly. Their patient mobile app and OARS technology have shown impressive results in improving patient engagement and adherence.

Additionally, their telehealth capabilities provide secure and convenient video sessions for patients and their healthcare teams, ensuring all treatment support is easily accessible within one platform. Q2i's solutions have been tested and validated through clinical studies with academic partners, proving their effectiveness in various areas of substance use disorder treatment. Users praise Q2i's technology for its ease of use, user-friendliness, and the improved communication it facilitates between patients and healthcare providers.

It helps providers give informed care by providing insight into patients' lives, while patients appreciate the convenience and confidence that comes with clear, effective communication. Overall, Q2i's innovative, evidence-based technology is transforming the landscape of substance use disorder treatment by enhancing patient engagement, adherence, and communication, ultimately improving long-term success rates and patient outcomes